Enjoy complimentary customisation on priority with our Enterprise License!
The smart pills drug delivery market size is estimated to grow by USD 5.45 billion at a CAGR of 20.62% between 2023 and 2028. Chronic diseases, particularly gastrointestinal disorders, are on the rise, fueling a significant increase in demand for advanced diagnostic tools. One such innovation is the capsule endoscope, a minimally invasive diagnostic device that provides high-resolution images of the entire gastrointestinal tract. The reimbursement approval of these diagnostic and screening capsule endoscopes by various health authorities is further driving market growth. Additionally, the rise in awareness and demand for bowel scope screening, especially for early detection and prevention of colorectal cancer, is expected to boost the market's expansion. This cutting-edge technology offers numerous benefits, including improved patient comfort, enhanced diagnostic accuracy, and reduced healthcare costs. The global capsule endoscopy market is poised for robust growth, driven by these key factors.
For More Highlights About this Report, Request Free Sample
The market refers to the segment of the pharmaceutical industry focused on developing innovative drug delivery systems that improve treatment adherence and enhance the efficacy of various therapeutics. Traditional dosage forms like oral therapies face challenges such as poor patient compliance due to factors like bioavailability and permeability issues. To address these concerns, the focus is shifting towards advanced drug delivery systems, particularly those designed for the oral administration of biologics like proteins and peptides. These delivery systems aim to overcome physical barriers in the GI tract, including the digestion of food and the presence of enzymes, by utilizing formulation strategies such as enteric coatings and targeted release mechanisms. The buccal cavity and esophagus are also being explored as alternative sites for drug delivery, with macroscale devices and swallowability being key considerations. Physical characteristics, such as size, shape, and texture, are crucial factors in the design of smart pills. The transit time through the GI tract and the bioavailability of macromolecules are also critical aspects of drug delivery, with permeability and physiological aspects playing essential roles in ensuring effective therapeutic outcomes. Overall, the market for smart pills is expected to grow significantly in the coming years as researchers continue to develop innovative delivery strategies to improve patient compliance and maximize the efficacy of various therapeutic agents. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The rising prevalence of chronic diseases is notably driving market growth. The Smart Pills Drug Delivery Market is experiencing significant growth due to the increasing demand for advanced drug delivery systems, particularly for treating chronic diseases. The epithelial lining barrier, composed of epithelial cells, presents a challenge for the effective delivery of macromolecules such as proteins, peptides, and enzymes. Traditional delivery methods, including generic capsules and tablets, have limitations in terms of bioavailability and site-specific targeting. To address these challenges, novel drug delivery strategies, such as smart pills, are being developed.
Further, these millimeter-scale devices employ various techniques, including controlled release, enhanced absorption, and site-specific targeting, to improve drug efficacy. They can traverse the epithelial lining through the paracellular and transcellular pathways or be taken up by M cells via endocytosis. Smart pills can deliver drugs directly to the target site, bypassing the first-pass metabolism and reducing the need for high drug loading capacity in the API. These physical characteristics, such as mucus adhesion and penetration abilities, are crucial for the success of smart pills. Preclinical and clinical studies are underway to evaluate the efficacy and safety of these novel drug delivery systems for various diseases, including diabetes, cancer, and cardiovascular diseases. Inorganic salts and cholesterol can be used in the design of smart pills to improve their performance. For instance, inorganic salts can enhance the drug loading capacity, while cholesterol can improve the swallowability and stability of the pills. As the demand for effective drug delivery systems continues to grow, the market for smart pills is expected to expand significantly. Thus, such factors are driving the growth of the market during the forecast period.
Increased patient preference for minimally invasive surgeries is the key trend in the market. The aging population is susceptible to various gastrointestinal disorders, leading to a significant demand for advanced drug delivery systems. Smart pills, including capsules and tablets, are under investigation for their potential application in therapeutics and disease diagnosis. Patients with chronic conditions requiring precise medication doses at specific sites represent a substantial market for these innovative drug delivery solutions. The trend towards minimally invasive procedures, such as capsule endoscopy, is driving the development of new techniques. Capsule endoscopy offers advantages like ease of administration and comprehensive observation of the gastrointestinal tract. This technology plays a crucial role in the early diagnosis and effective treatment of gastrointestinal disorders, as well as hybrid imaging technologies and novel component innovations. Water, inorganic salts, and enzymes are crucial components in the design of smart pills.
Moreover, these delivery systems can bypass the epithelial lining barrier through the paracellular or transcellular pathway, utilizing M cells, endocytosis, or antigen presentation. The bioavailability of macromolecules like proteins and peptides is enhanced through site-specific targeting. Delivery strategies employ macroscale devices, such as tablets and generic capsules, with considerations for swallowability, physical characteristics, drug loading capacity, API potency, mucus adhesion, and penetration abilities. Novel millimeter-scale devices, like smart pills, offer controlled release and enhanced absorption, contributing to the pharmaceutics industry's systemic effects. Preclinical and clinical studies are ongoing to evaluate the safety and efficacy of these advanced drug delivery systems, with subcutaneous applications also under exploration. Thus, such trends will shape the growth of the market during the forecast period.
The stringent government regulations related to drugs is the major challenge that affects the growth of the market. Regulatory authorities meticulously assess drug data to ensure safety and efficacy before granting approval. Factors such as pharmacological properties, pharmacodynamic effects, and drug interactions are scrutinized during the evaluation process. Failure to meet these criteria may result in a Complete Response Letter (CRL) or outright rejection from regulatory agencies. In response to a CRL, drug applicants must provide additional data, which may necessitate further clinical trials and increased R&D expenses. In some instances, applicants choose to abandon their applications and terminate drug development projects. In the realm of drug delivery systems, the development of smart pills, which include water-soluble capsules and tablets, has gained significant attention due to their potential to enhance the bioavailability of macromolecules such as proteins, peptides, and cholesterol. These delivery systems employ various techniques, including site-specific targeting, endocytosis, and mucus adhesion, to penetrate the epithelial lining barrier and reach the systemic circulation. Smart pills are designed using delivery strategies that optimize their physical characteristics, such as volume, drug loading capacity, and API potency, to ensure swallowability and controlled release. Novel millimeter-scale devices, including inorganic salts and enzymes, are being explored to improve the penetration abilities of these delivery systems.
Also, preclinical and clinical studies are underway to evaluate the efficacy and safety of these advanced drug delivery systems. Regulatory authorities closely monitor the development of these drug delivery systems, as they may offer significant advantages over traditional dosage forms. However, the complex design and delivery mechanisms of these systems necessitate rigorous testing and evaluation to ensure safety and efficacy. Therefore, it is essential to conduct comprehensive preclinical and clinical studies to assess the pharmacokinetics, pharmacodynamics, and systemic effects of these advanced drug delivery systems. In summary, the development of smart pills and other advanced drug delivery systems holds great promise for improving the bioavailability and efficacy of various therapeutic agents. However, the complex design and delivery mechanisms of these systems necessitate rigorous testing and evaluation to ensure safety and efficacy, as regulatory authorities closely scrutinize these data before granting approval. Hence, the above factors will impede the growth of the market during the forecast period.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
CapsoVision Inc. - The company offers drug delivery systems called CapsoCam Plus capsule endoscope and CapsoRetrieve, a single-use kit provided to patients for the collection, storage, and transportation of the CapsoCam Plus capsule.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The capsule endoscopy segment is estimated to witness significant growth during the forecast period. The market encompasses innovative technologies designed to improve the bioavailability of macromolecules, including water-soluble drugs like cholesterol-lowering agents, and insoluble ones, such as proteins and peptides.
Get a glance at the market share of various regions Download the PDF Sample
The capsule endoscopy segment accounted for USD 1.54 billion in 2018. Delivery strategies employ various mechanisms, including the epithelial lining barrier's transcellular and paracellular pathways, M cells, and endocytosis, to facilitate antigen transport and site-specific targeting. Designing effective delivery systems involves considering physical characteristics, such as swallowability, volume, drug loading capacity, and API potency. Inorganic salts and enzymes may be utilized to enhance absorption and penetration abilities. Novel millimeter-scale devices, referred to as smart pills, employ controlled release and enhanced absorption techniques for systemic effects. Preclinical and clinical studies using model drugs have demonstrated the potential of these advanced delivery systems, with promising results in subcutaneous administration. These delivery strategies aim to overcome challenges posed by the epithelial cells' mucus adhesion and penetration abilities. By employing techniques like endocytosis and site-specific targeting, macromolecules can bypass the epithelial lining barrier, increasing their bioavailability and efficacy. Smart pills, with their controlled release and enhanced absorption properties, represent a significant advancement in pharmaceutics, offering potential solutions to various therapeutic challenges.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 43% to the growth of the global market during the market forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The market encompasses innovative approaches to overcome challenges associated with traditional dosage forms, particularly in ensuring treatment adherence and delivering biologics via oral therapies. Formulation strategies for oral drug delivery focus on enhancing bioavailability through various techniques, including lumen-release of drugs using 3D-printed capsules and personalized medicine. The gastrointestinal tract poses physical barriers, such as mucus interfaces, epithelium injections, and tight junctions in the crypts and microvilli structures. Understanding the physiological aspects, including digestion of food, transit time, and the role of digestive enzymes and bile salts, is crucial in developing effective oral drug delivery systems. Technologies like gastrointestinal patches, esophageal injections, and buccal or sublingual administration offer prolonged residence time and improved permeability. In the large intestine, bacterial enzymes and mucus further complicate drug delivery, necessitating advanced formulation strategies.
The market report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD Billion " for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The market is witnessing significant advancements as researchers focus on overcoming challenges associated with traditional dosage forms, particularly in ensuring treatment adherence and delivering biologics. Oral therapies remain the most common administration route due to their ease and patient compliance. However, oral drug delivery faces hurdles such as bioavailability and physical barriers in the gastrointestinal (GI) tract. Formulation strategies like lumen-release of drugs, 3D-printed capsules, and personalized medicine are being explored to address these challenges. Small drug compounds, often problematic in traditional forms, can be effectively delivered using these advanced methods. The GI tract, including the buccal cavity, esophagus, and large intestine, poses unique challenges due to its physiological aspects, such as the digestion of food, mucus interfacing, and the presence of digestive enzymes and bile salts. These factors impact the permeability of the mucosal layer and tight junctions, affecting drug delivery. Innovative approaches like gastrointestinal patches, epithelium injections, and sublingual administration are being researched to bypass these barriers and ensure prolonged residence time in the target area. Understanding the physiological aspects of the GI tract, including the crypts, microvilli structures, and intercellular tight junctions, is crucial in developing effective drug delivery systems. In conclusion, the Smart Pills Drug Delivery market is at the forefront of revolutionizing drug administration, offering promising solutions to overcome the challenges associated with traditional dosage forms and improve patient outcomes.
Market Scope |
|
Report Coverage |
Details |
Page number |
135 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 20.62% |
Market growth 2024-2028 |
USD 5.45 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
16.56 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 43% |
Key countries |
US, UK, Japan, Germany, and France |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
AnX Robotics, CapsoVision Inc., Check-Cap Ltd., etectRx, General Electric Co., HQ Inc., Insulet Corp., IntroMedic Co. Ltd., Jinshan Science and Technology Group Co. Ltd., Koninklijke Philips N.V., Medtronic Plc, Olympus Europa SE and Co. KG, Otsuka Holdings Co. Ltd., RF Co. Ltd., and Shenzhen Zifu Medical Technology Co. Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.